Angiogenesis is essential for development, tissue repair, and vascular homeostasis, whereas dysregulated neovascularization contributes to chronic inflammation, ischemic injury, and cancer progression. Viral infections can reshape vascular programs through endothelial signaling, immune responses, metabolic stress, and...
Qamar Abuhassan, Waleed K. Abdulsahib, Sanan Thaer Abdalwahab et al.· Cancer Treatment and Researc...· 0 citations
The biological roles, biomarker potential, therapeutic applications, and methodological challenges of EVs in AML are summarized and the priorities required for their future clinical development are highlighted.
G. Oriquat, Shaker Al-Hasnaawei, Hayjaa Mohaisen Mousa et al.· European Journal of Haematol...· 0 citations
Overall, EV-ncRNAs represent promising mechanistic biomarkers and therapeutic targets, but rigorous source-specific validation and standardized analytical workflows are required before clinical implementation.
T. AlRamadneh, Waleed K. Abdulsahib, Sanan Thaer Abdalwahab et al.· Cancer Treatment and Researc...· 0 citations
Taken together, anti-PD-1 scFvs represent a modular platform for localized checkpoint inhibition and potentially improved cost-effectiveness compared with systemic antibodies.
Zahraa A. Alkhafaje, H. Malathi, A. Dash et al.· Cancer Chemotherapy and Phar...· 0 citations
This review synthesizes recent nanomedicine strategies that aim to bridge the gap between biomarker-oriented nanosensors and imaging probes for earlier detection with targeted nanocarriers designed to overcome delivery barriers, particularly the blood–brain barrier, while improving pharmacokinetics and limiting off-tar...
M. Ardah, Baraa Mohammed Yaseen, H. Malathi et al.· Discover Nano· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
